60089-53-4

Basic information

• Product Name: diisopropyl tetrasulphide
• Synonyms: diisopropyl tetrasulphide;Diisopropyl pertetrasulfide;ICD-1587;Einecs 262-051-7;Diisopropyl tetrasulfide
• CAS NO: 60089-53-4
• Molecular Formula: C₆H₁₄S₄
• Molecular Weight: 214.43536
• EINECS: 262-051-7
• Mol File: 60089-53-4.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 291.9°C at 760 mmHg
• Flash Point: 128.1°C
• Appearance: /
• Density: 1.164g/cm³
• Vapor Pressure: 0.00331mmHg at 25°C
• Refractive Index: 1.585
• CAS DataBase Reference: diisopropyl tetrasulphide(CAS DataBase Reference)
• NIST Chemistry Reference: diisopropyl tetrasulphide(60089-53-4)
• EPA Substance Registry System: diisopropyl tetrasulphide(60089-53-4)

Safety Data

• Hazardous Substances Data: 60089-53-4(Hazardous Substances Data)

Usage

InChI:InChI=1/C6H14S4/c1-5(2)7-9-10-8-6(3)4/h5-6H,1-4H3

Upstream product

• 67-64-1 acetone 
• 75-33-2 2-propanethiol 
• 7783-06-4 hydrogen sulfide 
• 10025-67-9 disulfur dichloride 
• 75-26-3 isopropyl bromide 

Relevant articles and documents

From symmetrical tetrasulfides to trisulfide dioxides: Via photocatalysis

A straightforward strategy involving photocatalysis has been established for accessing trisulfide dioxides from readily achieved symmetrical tetrasulfides. Stern-Volmer analysis and radical quenching experiments demonstrated the occurrence of a single electron transfer between the photocatalyst and sulfinic acid. Bioactive molecules such as the antihypertensive drug captopril, allicin derivatives, amino acids and terpenes were efficiently and reversibly linked through sulfur-sulfur covalent bonds. Furthermore, flow-setup syntheses of trisulfide dioxides were successfully achieved on the gram scale, indicating the great potential of the developed protocol for practical industrial applications. This journal is

ANTIBACTERIAL S-HETEROSUBSTITUTED DISULFIDES

Synthetically-derived S,S-heterodisubstituted disulfides that exhibit potent in vitro antibacterial activity against a variety of bacteria, including Staphylococcus aureus, methicillin-resistant Staphylococcus aureus and Francisella tularensis. The present invention provides compounds, methods and compositions effective to treat microbial/bacterial infections, and, especially, infections arising from bacteria which have developed resistance to conventional antibiotics.

REACTION OF SULFUR DIOXIDE WITH THIOLS CATALYZED BY BORON TRIFLUORIDE ETHERATE. EVIDENCE FOR A POSSIBLE INTERVENTION OF DITHIOSULFITE AS A REACTION INTERMEDIATE.

The reaction of sulfur dioxide (SO//2) with 1-propanethiol (NPT), 2-propanethiol (IPT), or 2-methyl-2-propanethiol (TBT) catalyzed by boron trifluoride ethrate (BF//3OEt//2) was investigated. The ratios of dialkyl trisulfide to dialkyl disulfide obtained (RSSSR/RSSR) at an early stage of the reaction were larger than 1 for the reaction of TBT and less than 1 for the reaction of NPT or IPT. The reaction of dithiosulfites with BF//3OEt//2 in the presence or absence of thiol was investigated. From a consideration of the similarity of the composition of the sulfides formed in the reaction of dithiosulfites with BF//3OEt//2 to those in the reaction of SO//2 witn thiol in the presence of BF//3OEt//2, the possibility of the intervention of dithiosulfite as a reaction intermediate in the reaction of SO//2 with thiol is discussed.